DIANA HEWLETT: Open Payments
NPI 1427027481 · MANAHAWKIN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$906 in 41 payments from 8 companies in 2025. Trend: 2023 $393 · 2024 $655 · 2025 $906
Food & beverage: $906
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 20 | $297 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 15 | $191 |
| ABBVIE INC. | 1 | $116 |
| Aimmune Therapeutics, Inc. | 1 | $103 |
| AstraZeneca Pharmaceuticals LP | 1 | $74 |
| Lilly USA, LLC | 1 | $72 |
| Boston Scientific Corporation | 1 | $30 |
| Globus Medical, Inc. | 1 | $24 |
Products named: Belbuca, RELISTOR, VRAYLAR, ZENPEP, AIRSUPRA, MOUNJARO, General - Pain Management, Senza.
Industry payments across NJ — which companies pay providers there.
